Pages that link to "Q34862962"
Jump to navigation
Jump to search
The following pages link to Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis (Q34862962):
Displaying 50 items.
- Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "Reactive" Biliary Epithelial Phenotype (Q26765903) (← links)
- Promising Therapy Candidates for Liver Fibrosis (Q26766727) (← links)
- Controversies over the Epithelial-to-Mesenchymal Transition in Liver Fibrosis (Q26771108) (← links)
- Pathogenesis of Type 2 Epithelial to Mesenchymal Transition (EMT) in Renal and Hepatic Fibrosis (Q26771232) (← links)
- Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development (Q26781761) (← links)
- EMT and interstitial lung disease: a mysterious relationship (Q26824760) (← links)
- Diverse functions of matrix metalloproteinases during fibrosis (Q26825368) (← links)
- What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis (Q26850229) (← links)
- Host responses in tissue repair and fibrosis (Q26852800) (← links)
- Recent developments in myofibroblast biology: paradigms for connective tissue remodeling (Q26863751) (← links)
- The role of the myofibroblast in tumor stroma remodeling (Q26997815) (← links)
- Bone marrow-derived fibrocytes contribute to liver fibrosis (Q27021576) (← links)
- The Role of Mesothelial Cells in Liver Development, Injury, and Regeneration (Q28066412) (← links)
- Cirrhosis and autoimmune liver disease: Current understanding (Q28070154) (← links)
- New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article (Q28070168) (← links)
- Epithelial-mesenchymal transition: An emerging target in tissue fibrosis (Q28083351) (← links)
- Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury (Q30414261) (← links)
- MiRNAs in kidney transplantation: potential role as new biomarkers (Q30456341) (← links)
- Esophageal epithelial cells acquire functional characteristics of activated myofibroblasts after undergoing an epithelial to mesenchymal transition (Q30656354) (← links)
- Mechanisms of fibrogenesis in liver cirrhosis: The molecular aspects of epithelial-mesenchymal transition (Q33563882) (← links)
- Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. (Q33762356) (← links)
- The origin of fibrogenic myofibroblasts in fibrotic liver (Q33811966) (← links)
- Immunohistochemical study for the origin of ductular reaction in chronic liver disease (Q34029126) (← links)
- Origin of myofibroblasts in the fibrotic liver in mice (Q34060761) (← links)
- Expansion of prominin-1-expressing cells in association with fibrosis of biliary atresia (Q34098245) (← links)
- Col1A1 production and apoptotic resistance in TGF-β1-induced epithelial-to-mesenchymal transition-like phenotype of 603B cells (Q34510956) (← links)
- Identification and characterization of mesenchymal-epithelial progenitor-like cells in normal and injured rat liver (Q34780806) (← links)
- Foxl1-Cre-marked adult hepatic progenitors have clonogenic and bilineage differentiation potential (Q35033882) (← links)
- TGF-β stimulation in human and murine cells reveals commonly affected biological processes and pathways at transcription level (Q35179134) (← links)
- Up-regulation of Hedgehog pathway is associated with cellular permissiveness for hepatitis C virus replication. (Q35489968) (← links)
- Potent natural products and herbal medicines for treating liver fibrosis (Q35494410) (← links)
- Recent advances in the pathogenesis and management of biliary atresia (Q35660652) (← links)
- Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a (Q35878960) (← links)
- Hepatic Deficiency of Augmenter of Liver Regeneration Exacerbates Alcohol-Induced Liver Injury and Promotes Fibrosis in Mice (Q35903869) (← links)
- The crucial role of cholangiocytes in cholangiopathies (Q36113261) (← links)
- Cell signals influencing hepatic fibrosis (Q36220879) (← links)
- Origin of fibrosing cells in systemic sclerosis (Q36264658) (← links)
- Experimental models of liver fibrosis (Q36442525) (← links)
- The origin, biology, and therapeutic potential of facultative adult hepatic progenitor cells (Q36450461) (← links)
- HDAC inhibitors in experimental liver and kidney fibrosis (Q36588493) (← links)
- Hepatic regeneration and the epithelial to mesenchymal transition (Q36699261) (← links)
- Smoothened is a master regulator of adult liver repair (Q36890924) (← links)
- Contribution of Myofibroblasts of Different Origins to Liver Fibrosis (Q37128332) (← links)
- Autocrine regulation of biliary pathology by activated cholangiocytes (Q37175512) (← links)
- Experimental liver fibrosis research: update on animal models, legal issues and translational aspects (Q37363773) (← links)
- The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development (Q37415641) (← links)
- Evidence for and against epithelial-to-mesenchymal transition in the liver (Q37440129) (← links)
- TGF-β in progression of liver disease (Q37946756) (← links)
- Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside (Q38018841) (← links)
- Genesis of the myofibroblast in lung injury and fibrosis (Q38026812) (← links)